BioXcel Therapeutics, Inc. Capital Expenditures
BioXcel Therapeutics, Inc. (BTAI) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00.
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $0.00.
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $20.00K, a 85.61% decline from fiscal 2022.
- BioXcel Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $139.00K, a 68.76% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $20.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $20.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $20.00K 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $0.00 derived: sum of 2 quarters · filed 2024-03-22 | $19.00K derived: sum of 3 quarters · filed 2024-03-22 | $139.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $19.00K derived: sum of 2 quarters · filed 2023-11-14 | $139.00K 10-Q · filed 2023-11-14 | $151.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $139.00K 10-Q · filed 2023-08-14 | $151.00K derived: sum of 3 quarters · filed 2023-08-14 | $168.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $120.00K 10-Q · filed 2023-05-09 | $132.00K derived: sum of 2 quarters · filed 2023-05-09 | $149.00K derived: sum of 3 quarters · filed 2023-05-09 | $249.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $29.00K derived: sum of 2 quarters · filed 2023-03-16 | $129.00K derived: sum of 3 quarters · filed 2023-03-16 | $445.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $117.00K derived: sum of 2 quarters · filed 2022-11-14 | $433.00K 10-Q · filed 2022-11-14 | $703.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $416.00K 10-Q · filed 2022-08-11 | $686.00K derived: sum of 3 quarters · filed 2022-08-11 | $681.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $316.00K 10-Q · filed 2022-05-09 | $586.00K derived: sum of 2 quarters · filed 2022-05-09 | $581.00K derived: sum of 3 quarters · filed 2022-05-09 | $616.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $265.00K derived: sum of 2 quarters · filed 2022-03-11 | $300.00K derived: sum of 3 quarters · filed 2022-03-11 | $316.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $30.00K derived: sum of 2 quarters · filed 2021-11-10 | $46.00K 10-Q · filed 2021-11-10 | $48.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $51.00K 10-Q · filed 2021-08-10 | $53.00K derived: sum of 3 quarters · filed 2021-08-10 | $96.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $16.00K 10-Q · filed 2021-05-10 | $18.00K derived: sum of 2 quarters · filed 2021-05-10 | $61.00K derived: sum of 3 quarters · filed 2021-05-10 | $286.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $45.00K derived: sum of 2 quarters · filed 2021-03-12 | $270.00K derived: sum of 3 quarters · filed 2021-03-12 | $870.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $268.00K derived: sum of 2 quarters · filed 2020-11-12 | $868.00K 10-Q · filed 2020-11-12 | $1.03M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $825.00K 10-Q · filed 2020-08-14 | $983.00K derived: sum of 3 quarters · filed 2020-08-14 | $1.04M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $600.00K 10-Q · filed 2020-05-12 | $758.00K derived: sum of 2 quarters · filed 2020-05-12 | $820.00K derived: sum of 3 quarters · filed 2020-05-12 | |
| 2018-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $220.00K derived: sum of 2 quarters · filed 2020-03-09 | $340.00K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $182.00K 10-Q · filed 2018-11-09 | ||
| 2018-06-30 | $120.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |